Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1996-3-19
|
pubmed:abstractText |
Molecular cloning has revealed the existence of four distinct transporters for the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), termed GAT-1, GAT-2, GAT-3, and BGT-1. To determine which of the cloned transporters are in neurons and which are in glia, we have undertaken a combined pharmacological and molecular biological study using cell cultures derived from rat brain. In neuronal cultures approximately 70% of GABA transport is sensitive to the GAT-1-selective ligand NNC-711 and drug potencies at this site correlate well with their potencies at GAT-1; GAT-1 mRNA is abundant in these cultures as determined by northern blot analysis. Drug potencies at the NNC-711-resistant component correlate well with their potencies at GAT-2 and GAT-3, whose pharmacological profiles are similar to one another. Northern blots reveal the presence of mRNA for GAT-3 in neuronal cultures, whereas GAT-2 and BGT-1 mRNAs are not detected. Type 1 astrocyte cultures exhibit very low levels of GABA transport activity, which has very low potency for GABA but high potency for taurine. Such cultures have mRNA for a taurine transporter and BGT-1, but not for GAT-1, GAT-2, and GAT-3. In cultures containing O-2A progenitor cells and Type 2 astrocytes, approximately 75% of GABA uptake is sensitive to NNC-711 and drug potencies at this site correlate well with their potencies at GAT-1; GAT-1 mRNA is abundant. Drug potencies at the NNC-711-resistant component correlate well with their potencies at GAT-2 and GAT-3; mRNAs for both of these transporters are present (though GAT-2 mRNA is the more abundant), as is BGT-1 mRNA. In summary, these data demonstrate heterogeneity of both neuronal and glial GABA transport.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1060-6823
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
129-46
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8581400-Animals,
pubmed-meshheading:8581400-Astrocytes,
pubmed-meshheading:8581400-Biological Transport,
pubmed-meshheading:8581400-Blotting, Northern,
pubmed-meshheading:8581400-Carrier Proteins,
pubmed-meshheading:8581400-Cells, Cultured,
pubmed-meshheading:8581400-Cloning, Molecular,
pubmed-meshheading:8581400-Neurons,
pubmed-meshheading:8581400-RNA, Messenger,
pubmed-meshheading:8581400-Rats,
pubmed-meshheading:8581400-Rats, Sprague-Dawley,
pubmed-meshheading:8581400-gamma-Aminobutyric Acid
|
pubmed:year |
1995
|
pubmed:articleTitle |
Re-evaluation of GABA transport in neuronal and glial cell cultures: correlation of pharmacology and mRNA localization.
|
pubmed:affiliation |
Department of Pharmacology, Synaptic Pharmaceutical Corporation, Paramus, NJ 07652, USA.
|
pubmed:publicationType |
Journal Article
|